Did Christopher Jacobs buy Amylyx Pharmaceuticals stock?

Common questions

Did Christopher Jacobs buy Amylyx Pharmaceuticals stock?

Yes. Christopher Jacobs disclosed 1 purchase of Amylyx Pharmaceuticals (AMLX) stock on Oct 12, 2022, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Christopher Jacobs's Amylyx Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Christopher Jacobs make these Amylyx Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Christopher Jacobs still own Amylyx Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Christopher Jacobs report these trades?

The latest filing is dated Nov 16, 2022. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.